

Founders
Dr. Ho has been a world leading authority in AIDS research for 25
years while publishing over 350 papers. He championed combination
antiretroviral therapy that has resulted in unprecedented control of HIV in
patients. Among Dr. Ho’s many honors include his election to the membership of
the American Academy of Arts and Sciences; Institute of Medicine, National
Academy of Science in the United States; Academia Sinica (Republic of China);
and Chinese Academy of Engineering. Dr. Ho also holds the rare honor of
simultaneously serving on Board of Trustees of the California Institute of
Technology and the Board of the Massachusetts Institute of Technology
Corporation.
Dr. Chen co-founded TaiMed Biologics USA with Dr. Ho and has been a member of the Board of Directors since inception. Dr. Chen is a Professor Pathology, Emeritus, at Harvard Medical School. He has been at the Dana-Farber Cancer Institute and Harvard Medical School since July 1977. Dr. Chen is the founder of several biotechnology companies, including Fuji ImmunoPharmaceuticals Corp. and Shionogi BioResearch Corp. Dr. Chen received his B.S. in chemistry from National Taiwan University and his Ph.D. in cell biology from the Massachusetts Institute of Technology.
Executive
Team
James Chang, Chief Executive Officer
Bryan Keaney, Chief Financial Officer
Stanley T. Lewis, Chief Medical Officer and Vice President, Clinical Development
Helen Shu, Vice President, Regulatory Affairs and Quality
Steven Weinheimer, Senior Director, Biological Sciences
Jonathan Ho, Manager of Business Development & Alliance Management